Aurinia Pharmaceuticals (AUPH) PT Raised to $28 at Oppenheimer, Following Clinical Update

January 25, 2021 12:26 PM EST
Get Alerts AUPH Hot Sheet
Price: $11.87 -0.75%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 16 | New: 68
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Oppenheimer analyst Justin Kim raised the price target on Aurinia Pharmaceuticals (NASDAQ: AUPH) to $28.00 (from $20.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change